TV News LIES

Friday, May 25th

Last update05:20:13 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


Trump spending cuts allowed to target kids’ health insurance

Gov't Accounting Office gives OK to cut childern's health inusrance The Government Accountability Office on Tuesday delivered a victory to the Trump administration by greenlighting a...

CDC: U.S. birth rate hit 30-year low in 2017

US birthrate lowest in 30 years The birth rate for nearly every group of women in the United States fell to...

Trump targets Planned Parenthood, family planning services with new abortion rule

Alex Azar with Trump, tie abortion to all health servicesThe Trump administration moved forward with a proposal Friday that would effectively ban Planned Parenthood and...

Melania Trump treated for benign kidney condition, in hospital

Melania Trump in hospitalPresident Donald Trump’s wife, Melania Trump, has been treated for what was described as a benign...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!